Literature DB >> 24960052

Genome analysis of Mayaro virus imported to Germany from French Guiana.

Barbara Friedrich-Jänicke, Petra Emmerich, Dennis Tappe, Stephan Günther, Daniel Cadar, Jonas Schmidt-Chanasit.   

Abstract

Entities:  

Keywords:  French Guiana; Germany; Mayaro virus; genome analysis; travel; viruses

Mesh:

Year:  2014        PMID: 24960052      PMCID: PMC4073840          DOI: 10.3201/eid2007.140043

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Mayaro virus (MAYV), a mosquito-borne New World alphavirus of the family Togaviridae, causes a febrile arthralgia syndrome resembling dengue and chikungunya fever. The virus is maintained in a natural cycle involving nonhuman primates and Haemagogus spp. mosquitoes in tropical rainforest areas of South America (). After an incubation time of 7–12 days following an infectious mosquito bite, rash, fever, headache, and arthralgia develop in patients, followed by restoration to their original conditions after several weeks (). Outbreaks of Mayaro fever have been reported from the Amazon region (,). There are increasing reports of travel-related infections imported from South America to Europe and the United States (–). We describe an acute MAYV infection in a German traveler who returned from French Guiana. Full-length MAYV genome amplification was performed on virus obtained from a serum sample of the patient. In August 2013, a 44-year-old woman (bookkeeper) came to an outpatient clinic with fever (temperature ≤38.7°C), chills, a mild headache, severe fatigue, highly painful swelling of small finger joints, and pain in both feet. Symptoms appeared 2 days before when she experienced aches in her wrists and left forefoot. Four days before, the patient had returned from a 2.5-week visit to French Guiana, where she traveled with her partner and caught butterflies. She had conducted these activities during her holidays for the past 5 years, mostly in spring or autumn. In July 2013 at the end of the rainy season, she had many mosquito bites, especially on her hands, despite use of repellents and bed nets. Physical examination showed a body temperature of 38°C, throat enanthema, generalized macular exanthema, and slightly swollen and tender interphalangeal joints of the hands and feet. Her medical history was unremarkable, and her partner was asymptomatic. Laboratory tests showed reference values for hemoglobin concentration; platelet count; and levels of liver enzymes, creatinine, and anti-nuclear and anti–citrulline peptide antibodies. C-reactive protein level was increased (24.2 mg/L; reference value <5 mg/L), and serum lactate dehydrogenase level was slightly increased (4.4 μkat/L; reference value <4.12 μkat/L). Leukopenia (2.4 G/L; reference value 4.0–10.0 G/L) was present, which intensified the next day (2.0 g/L). The leukocyte count returned to a reference value 8 days after disease onset and the patient fully recovered. Malaria, dengue fever, and rickettsiosis were excluded by using several tests. Blood cultures obtained on day 2 after disease onset remained sterile, and a viral infection was suspected. Follow-up investigation on day 16 of illness showed an increased IgG titer (80) against chikungunya virus (by indirect immunofluorescence assay; reference value <1:20) () but no IgM titer. Additional tests for alphaviruses were then performed on the same sample, and indirect immunofluorescence assay showed an IgM titer of 2,560 and an IgG titer of 10,240 (reference value <20) () against MAYV. Results of serologic tests were negative for Venezuelan equine encephalitis virus, Eastern equine encephalitis virus, and Oropouche virus. IgM (80) and IgG (160) titers for antibodies against Ross River virus were low. An acute MAYV infection was strongly suspected and a stored serum sample from day 2 underwent generic reverse transcription PCR (RT-PCR) for alphaviruses with primers VIR2052F (5′-TGGCGCTATGATGAAATCTGGAATGTT-3′) and VIR2052R (5′-TACGATGTTGTCGTCGCCGATGAA-3′) () and quantitative MAYV real-time RT-PCR (in-house) with primers MayaroF (5′-CCTTCACACAGATCAGAC-3′), MayaroR (5′-GCCTGGAAGTACAAAGAA-3′), probe labeled with 6- carboxyfluorescein (FAM) and black hole quencher 1 (BHQ-1) MayaroP (5′-FAM-CATAGACATCCTGATAGACTGCCACC-BHQ1–3′) by using the AgPath-ID One-Step RT-PCR Kit (Life Technologies, Carlsbad, CA, USA) according to the manufacturer’s instructions. The generic RT-PCR for alphaviruses showed a positive result, and direct sequencing of the amplicon showed a MAYV-specific sequence. The serum sample had an MAYV viral load of 1.24 × 107 copies/mL when in vitro–transcribed RNA from a reference plasmid was used as a quantification standard. Attempts to isolate MAYV in cell culture were not successful. Therefore, the serum sample was used to obtain the complete MAYV genome sequence by using primers designed from multiple alignments of the MAYV genomes obtained from databases. (Primer sequences used are available on request.) The complete MAYV genome (strain BNI-1, KJ013266) was amplified from the serum sample, and phylogenetic analysis of a 2-kb genomic fragment showed that strain BNI-1 belonged to genotype D () and is closely related to strains circulating in Brazil (Figure, Appendix).
Figure

Bayesian maximum clade credibility tree representing the time-scale phylogeny of Mayaro virus (MAYV) by analysis of 2-kb genomic fragments, including the 3′ segment of the envelope (E)2 protein, the complete E1 protein, and the 3′ non-coding region (NCR). Phylogenetic analysis was performed by using Bayesian Markov chain Monte Carlo (MCMC) tree-sampling method implemented in BEAST (http://beast.bio.ed.ac.uk). The general time reversible model of nucleotide substitution with gamma distributed rate variation among sites and a relaxed (uncorrelated log-normal) molecular clock model were used. Two independent runs of 5 × 107 generations with a burn in of 5 × 106 generations were performed to estimate the posterior probability distribution. Convergence of parameters was confirmed by calculating the effective sample size with Tracer v1.4 (http://tree.bio.ed.ac.uk/software/tracer/) and excluding an initial 10% for each run. The maximum clade credibility tree obtained (tree with the largest product of posterior clade probabilities) was selected from the posterior tree distribution after a 10% burn in by using the TreeAnnotator (http://beast.bio.ed.ac.uk/TreeAnnotator). Taxon information includes GenBank accession number, strain designation, and country of origin. Branches are colored on the basis of the most probable location state of the descendent nodes (see color codes). The posterior probabilities (clade credibilities ≥90%) and the time to most recent common ancestor of the major branches are shown. Date of divergence (95% highest posterior density) of the genotypes, subtypes, and the MAYV strain isolated in this study (in orange) are given. Scale bar indicates years before the last sampling time (2013).

Bayesian maximum clade credibility tree representing the time-scale phylogeny of Mayaro virus (MAYV) by analysis of 2-kb genomic fragments, including the 3′ segment of the envelope (E)2 protein, the complete E1 protein, and the 3′ non-coding region (NCR). Phylogenetic analysis was performed by using Bayesian Markov chain Monte Carlo (MCMC) tree-sampling method implemented in BEAST (http://beast.bio.ed.ac.uk). The general time reversible model of nucleotide substitution with gamma distributed rate variation among sites and a relaxed (uncorrelated log-normal) molecular clock model were used. Two independent runs of 5 × 107 generations with a burn in of 5 × 106 generations were performed to estimate the posterior probability distribution. Convergence of parameters was confirmed by calculating the effective sample size with Tracer v1.4 (http://tree.bio.ed.ac.uk/software/tracer/) and excluding an initial 10% for each run. The maximum clade credibility tree obtained (tree with the largest product of posterior clade probabilities) was selected from the posterior tree distribution after a 10% burn in by using the TreeAnnotator (http://beast.bio.ed.ac.uk/TreeAnnotator). Taxon information includes GenBank accession number, strain designation, and country of origin. Branches are colored on the basis of the most probable location state of the descendent nodes (see color codes). The posterior probabilities (clade credibilities ≥90%) and the time to most recent common ancestor of the major branches are shown. Date of divergence (95% highest posterior density) of the genotypes, subtypes, and the MAYV strain isolated in this study (in orange) are given. Scale bar indicates years before the last sampling time (2013). In 2 clinic-based syndromic surveillance studies in South America, 0.8%–3% of febrile episodes were caused by MAYV infection (,). In travelers, MAYV infections were acquired in tropical rainforest or wildlife conservation areas () and were sometimes associated with insect-hunting activities (). Successful complete genome amplification of MAYV strain BNI-1 from a clinical sample might help identify regions in the MAYV genome that undergo rapid mutations caused by the isolation process in cell culture and improve phylogenetic and functional genome analysis. Moreover, the viral load in our patient was high enough for efficient transmission of MAYV to a susceptible mosquito vector (S. Becker, pers. comm.). Thus, in disease-endemic regions, patients with an acute MAYV infection should be protected from mosquito bites during the first week of disease to prevent spread of the virus.
  10 in total

1.  Imported Mayaro virus infection in the Netherlands.

Authors:  Robert-Jan Hassing; Isabelle Leparc-Goffart; Sybrandus N Blank; Subashini Thevarayan; Hugues Tolou; Gerard van Doornum; Perry J van Genderen
Journal:  J Infect       Date:  2010-06-19       Impact factor: 6.072

2.  Genetic relationships among Mayaro and Una viruses suggest distinct patterns of transmission.

Authors:  Ann M Powers; Patricia V Aguilar; Laura J Chandler; Aaron C Brault; Tiffany A Meakins; Douglas Watts; Kevin L Russell; James Olson; Pedro F C Vasconcelos; Amelia Travassos Da Rosa; Scott C Weaver; Robert B Tesh
Journal:  Am J Trop Med Hyg       Date:  2006-09       Impact factor: 2.345

3.  Infection with Mayaro virus in a French traveller returning from the Amazon region, Brazil, January, 2010.

Authors:  M C Receveur; M Grandadam; T Pistone; D Malvy
Journal:  Euro Surveill       Date:  2010-05-06

4.  Recurrent arthralgias in a patient with previous Mayaro fever infection.

Authors:  Shawn F Taylor; Paresh R Patel; Thomas J S Herold
Journal:  South Med J       Date:  2005-04       Impact factor: 0.954

5.  Arboviral etiologies of acute febrile illnesses in Western South America, 2000-2007.

Authors:  Brett M Forshey; Carolina Guevara; V Alberto Laguna-Torres; Manuel Cespedes; Jorge Vargas; Alberto Gianella; Efrain Vallejo; César Madrid; Nicolas Aguayo; Eduardo Gotuzzo; Victor Suarez; Ana Maria Morales; Luis Beingolea; Nora Reyes; Juan Perez; Monica Negrete; Claudio Rocha; Amy C Morrison; Kevin L Russell; Patrick J Blair; James G Olson; Tadeusz J Kochel
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

6.  Direct broad-range detection of alphaviruses in mosquito extracts.

Authors:  Mark W Eshoo; Chris A Whitehouse; Scott T Zoll; Christian Massire; Thuy-Trang D Pennella; Lawrence B Blyn; Rangarajan Sampath; Thomas A Hall; Joseph A Ecker; Anjali Desai; Leonard P Wasieloski; Feng Li; Michael J Turell; Amy Schink; Karl Rudnick; Glen Otero; Scott C Weaver; George V Ludwig; Steven A Hofstadler; David J Ecker
Journal:  Virology       Date:  2007-07-25       Impact factor: 3.616

7.  Mayaro virus infection in traveler returning from Amazon Basin, northern Peru.

Authors:  Andreas Neumayr; Martin Gabriel; Jasmin Fritz; Stephan Günther; Christoph Hatz; Jonas Schmidt-Chanasit; Johannes Blum
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

8.  Mayaro fever virus, Brazilian Amazon.

Authors:  Raimunda S S Azevedo; Eliana V P Silva; Valéria L Carvalho; Sueli G Rodrigues; Joaquim P Nunes-Neto; Hamilton Monteiro; Victor S Peixoto; Jannifer O Chiang; Márcio R T Nunes; Pedro F C Vasconcelos
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

9.  Prolonged polyarthralgia in a German traveller with Mayaro virus infection without inflammatory correlates.

Authors:  Christian Theilacker; Jürgen Held; Ludger Allering; Petra Emmerich; Jonas Schmidt-Chanasit; Winfried V Kern; Marcus Panning
Journal:  BMC Infect Dis       Date:  2013-08-08       Impact factor: 3.090

10.  Mayaro virus infection, Amazon Basin region, Peru, 2010-2013.

Authors:  Eric S Halsey; Crystyan Siles; Carolina Guevara; Stalin Vilcarromero; Erik J Jhonston; Cesar Ramal; Patricia V Aguilar; Julia S Ampuero
Journal:  Emerg Infect Dis       Date:  2013-11       Impact factor: 6.883

  10 in total
  8 in total

1.  Real-time RT-PCR for Mayaro virus detection in plasma and urine.

Authors:  Jesse J Waggoner; Alejandra Rojas; Alisha Mohamed-Hadley; Yvalena Arévalo de Guillén; Benjamin A Pinsky
Journal:  J Clin Virol       Date:  2017-11-21       Impact factor: 3.168

2.  Temperature-Mediated Effects on Mayaro Virus Vector Competency of Florida Aedes aegypti Mosquito Vectors.

Authors:  Abdullah A Alomar; Barry W Alto
Journal:  Viruses       Date:  2022-04-23       Impact factor: 5.818

3.  Sustained Elevated Cytokine Levels during Recovery Phase of Mayaro Virus Infection.

Authors:  Dennis Tappe; José Vicente Pérez-Girón; Gudrun Just-Nübling; Gernot Schuster; Sergio Gómez-Medina; Stephan Günther; César Muñoz-Fontela; Jonas Schmidt-Chanasit
Journal:  Emerg Infect Dis       Date:  2016-04       Impact factor: 6.883

4.  Chikungunya virus infections among travellers returning to Spain, 2008 to 2014.

Authors:  Maria Dolores Fernandez-Garcia; Mathieu Bangert; Fernando de Ory; Arantxa Potente; Lourdes Hernandez; Fatima Lasala; Laura Herrero; Francisca Molero; Anabel Negredo; Ana Vázquez; Teodora Minguito; Pilar Balfagón; Jesus de la Fuente; Sabino Puente; Eva Ramírez de Arellano; Mar Lago; Miguel Martinez; Joaquim Gascón; Francesca Norman; Rogelio Lopez-Velez; Elena Sulleiro; Diana Pou; Nuria Serre; Ricardo Fernández Roblas; Antonio Tenorio; Leticia Franco; Maria Paz Sanchez-Seco
Journal:  Euro Surveill       Date:  2016-09-08

5.  Mayaro virus in Latin America and the Caribbean.

Authors:  Niloofar Ganjian; Ana Riviere-Cinnamond
Journal:  Rev Panam Salud Publica       Date:  2020-02-11

6.  The Mayaro virus and its potential epidemiological consequences in Colombia: an exploratory biomathematics analysis.

Authors:  Bryan Steven Valencia-Marín; Irene Duarte Gandica; Oscar Alexander Aguirre-Obando
Journal:  Parasit Vectors       Date:  2020-10-08       Impact factor: 3.876

7.  Favipiravir Inhibits Mayaro Virus Infection in Mice.

Authors:  Michèle Bengue; Ai-Rada Pintong; Florian Liegeois; Antoine Nougairède; Rodolphe Hamel; Julien Pompon; Xavier de Lamballerie; Pierre Roques; Valérie Choumet; Dorothée Missé
Journal:  Viruses       Date:  2021-11-03       Impact factor: 5.048

Review 8.  Mayaro: an emerging viral threat?

Authors:  Yeny Acosta-Ampudia; Diana M Monsalve; Yhojan Rodríguez; Yovana Pacheco; Juan-Manuel Anaya; Carolina Ramírez-Santana
Journal:  Emerg Microbes Infect       Date:  2018-09-26       Impact factor: 7.163

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.